Skip to main content
Caplight Logo









Sibel Health

Sibel Health

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://sibelhealth.com/

Last Round

Grant

Apr 9, 2026

Total Funding Raised

$124.03M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Sibel Health is a healthcare technology company that develops clinical-grade health monitoring devices to track vital signs such as heart rate, respiratory rate, and skin temperature, utilizing advanced motion sensor technology for both clinical care and research applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

wearable patient monitoringremote patient monitoringRPMclinical-grade wearablesmaternal monitoringneonatal monitoringdigital healthcontinuous physiological monitoringclinical decision supportmedical IoTIoMTedema monitoringpatient surveillancewearable biosensorsclinical trial technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sibel Health Comparables

Compare Sibel Health with similar companies based on industry and business-model similarity.

Sibel Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioIntelliSense
85%
VitalConnect
83%
Bambi Medical
79%

Sibel Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 9, 2026
GrantDec 9, 2025
Series COct 14, 2025
Series C ExtensionOct 14, 2025
Series CMar 20, 2025
Grant
Apr 23, 2024

Key People

Founding team and executive leadership

Steve Xu

Chief Executive Officer

Executive Team

Jong Yoon Lee

Chief Technology Officer

Executive Team

Sibel Health Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2026

    Developing AI-powered features for ANNE(R) Maternal product.

  • Apr 9, 2026

    Secured $5M in grant funding.

Sibel Health Filings

Explore SEC and related filing metadata, where available.

Sibel Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sibel Health's valuation, stock price, and market status.

Is Sibel a public or private company?

Sibel is a private company.

What is the current stock price of Sibel?

Sibel is a private company with no public stock price. No recent secondary market data is available.

How much is Sibel worth (valuation)?

Valuation information for Sibel is not publicly available.

Can I buy Sibel stock?

Sibel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sibel's last funding round?

Sibel's most recent funding round was Grant on April 9, 2026.

Who are the main investors in Sibel?

Key investors in Sibel include Steele Foundation for Hope.

Will Sibel IPO soon?

No public IPO plans have been announced for Sibel.

How can I track Sibel secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sibel's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range70
Year Founded2018
Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?